Clinical Trials Browser

Phase NA × OTHER × epratuzumab × Clear all

NCT00398372 2011-06-02

Clinical and Pathologic Studies in Non-Hodgkin's Lymphoma Patients Receiving Antibody Treatment

Phase NA Completed

Lymphoma, Non-Hodgkin